Our blood vessels must remain sealed to prevent blood leakage. During blood vessel formation vascular cells are able to reinforce their cell junctions by employing a specific protein when exposed to great forces, University of Basel scientists report.
Following a comprehensive analysis of its salaries, the University of Basel has been awarded the “We Pay Fair” label by the University of St.Gallen’s Competence Centre for Diversity & Inclusion (CCDI), indicating that salaries at the University of Basel comply with the “equal pay for equivalent work” principle that is enshrined in the Swiss constitution.
The diagnosis is rare, but devastating – children with congenital muscle disorders often never learn to walk. Until now, there was no chance of recovery, but researchers at the University of Basel and University Hospital Basel are now presenting a possible therapeutic approach for the first time.
Quantum bits (qubits) are the smallest units of information in a quantum computer. Currently, one of the biggest challenges in developing this kind of powerful computer is scalability. A research group at the University of Basel, working with the IBM Research Laboratory in Rüschlikon, has made a breakthrough in this area.
A year after being infected with coronavirus, those affected are much more likely to suffer from typical long Covid symptoms, such as fatigue, than people who have never had a positive PCR test for coronavirus. This greater prevalence cannot be attributed to mental stress as a result of the pandemic. This is shown by the findings of the Swiss Corona Stress Study, conducted with more than 11,000 participants by the University of Basel.
Technological devices have become constant companions in our daily lives. For the first time, researchers at the University of Basel have now collected data to investigate whether smartwatches can be used to help with compulsive hand washing. Initial results are “cautiously promising.”
There is no other place where so many Neolithic pile dwellings have been uncovered as around the Alps. It is a mystery, however, how this “building boom” came to be. Researchers at the University of Basel have now uncovered new clues, and say that settlers at Lake Varese in northern Italy may have played a leading role.
Prof. Markus Rüegg and Dr. Judith Reinhard from the Biozentrum of the University of Basel have founded the start-up SEAL Therapeutics AG together with Dr. Thomas Meier, former CEO of Santhera Pharmaceuticals. Their goal is to treat congenital muscular dystrophy using gene therapy and to bring their research findings from the laboratory to the patient. To date, there is no treatment for this life-threatening genetic disease.
The spin-off Aukera Therapeutics, which was founded at the Biozentrum last year, has been selected for the start-up accelerator program BaseLaunch. The biotech company develops novel therapies for patients suffering from mTOR related diseases such as cancer and neurodegenerative diseases. mTOR plays a key role in cell growth control.
